FINE FOODS & PHARMACEUTICALS (FF.MI) Stock Price, Forecast & Analysis

BIT:FF • IT0005215329

11.525 EUR
+0.58 (+5.25%)
Last: Feb 20, 2026, 05:29 PM

FF.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap254.24M
Revenue(TTM)373.66M
Net Income(TTM)18.62M
Shares22.06M
Float9.22M
52 Week High11.75
52 Week Low6.46
Yearly Dividend0.12
Dividend Yield1.27%
EPS(TTM)0.89
PE12.95
Fwd PE16.41
Earnings (Next)03-11
IPO2016-10-19
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
FF.MI short term performance overview.The bars show the price performance of FF.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

FF.MI long term performance overview.The bars show the price performance of FF.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40 50

The current stock price of FF.MI is 11.525 EUR. In the past month the price increased by 12.44%. In the past year, price increased by 50.85%.

FINE FOODS & PHARMACEUTICALS / FF Daily stock chart

FF.MI Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to FF.MI. When comparing the yearly performance of all stocks, FF.MI is one of the better performing stocks in the market, outperforming 86.73% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
FF.MI Full Technical Analysis Report

FF.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to FF.MI. FF.MI has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
FF.MI Full Fundamental Analysis Report

FF.MI Financial Highlights

Over the last trailing twelve months FF.MI reported a non-GAAP Earnings per Share(EPS) of 0.89. The EPS increased by 147.03% compared to the year before.


Industry RankSector Rank
PM (TTM) 5.07%
ROA 6.89%
ROE 13.58%
Debt/Equity 0.44
Chartmill High Growth Momentum
EPS Q2Q%3.62%
Sales Q2Q%12.18%
EPS 1Y (TTM)147.03%
Revenue 1Y (TTM)1.78%
FF.MI financials

FF.MI Forecast & Estimates

12 analysts have analysed FF.MI and the average price target is 12.7 EUR. This implies a price increase of 10.19% is expected in the next year compared to the current price of 11.525.

For the next year, analysts expect an EPS growth of 53.89% and a revenue growth 4.41% for FF.MI


Analysts
Analysts86.67
Price Target12.7 (10.2%)
EPS Next Y53.89%
Revenue Next Year4.41%
FF.MI Analyst EstimatesFF.MI Analyst Ratings

FF.MI Ownership

Ownership
Inst Owners12%
Ins Owners53.17%
Short Float %N/A
Short RatioN/A
FF.MI Ownership

About FF.MI

Company Profile

FF logo image Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 660 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.

Company Info

FINE FOODS & PHARMACEUTICALS

Via Berlino, 39, Zingonia

Verdellino BERGAMO IT

Employees: 779

FF Company Website

FF Investor Relations

Phone: 390354821382

FINE FOODS & PHARMACEUTICALS / FF.MI FAQ

What does FF do?

Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 660 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.


Can you provide the latest stock price for FINE FOODS & PHARMACEUTICALS?

The current stock price of FF.MI is 11.525 EUR. The price increased by 5.25% in the last trading session.


What is the dividend status of FINE FOODS & PHARMACEUTICALS?

FINE FOODS & PHARMACEUTICALS (FF.MI) has a dividend yield of 1.27%. The yearly dividend amount is currently 0.12.


What is the ChartMill technical and fundamental rating of FF stock?

FF.MI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the analyst forecast for FF.MI stock?

12 analysts have analysed FF.MI and the average price target is 12.7 EUR. This implies a price increase of 10.19% is expected in the next year compared to the current price of 11.525.


Can you provide the growth outlook for FINE FOODS & PHARMACEUTICALS?

The Revenue of FINE FOODS & PHARMACEUTICALS (FF.MI) is expected to grow by 4.41% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.